Table 3: Overall survival according to demographic and clinical characteristic stratified against treatment modalities (n = 124).

Covariates

ACT

NACT

n = 93

OS (83.9%)

p-value

n = 31

OS (48.4%)

p-value

Age

< 50 years

≥ 50 years

 

31

62

 

96.8

77.4

0.013

 

14

17

 

57.1

41.2

0.562

Ethnic

Malay

Non-Malay

 

54

39

 

87.0

79.5

0.353

 

24

7

 

45.8

57.1

0.621

Stage

Early stage

Advanced stage

 

39

54

 

94.9

75.9

0.022

 

 

5

26

 

100.0

38.5

 

0.085

Molecular subtypes

Luminal A

TNBC

Other

 

36

13

44

 

86.1

84.6

81.8

0.445

 

6

5

20

 

80.0

40.0

50.0

0.701

Chemotherapy

Anthracycline based

Taxane based

Anthracycline+Taxane

 

57

3

33

 

80.7

33.3

93.9

0.002

 

1-2*

2-3**

 

23

3

5

 

56.5

33.3

60.0

0.184

Schedule modification

No Modification

With Modification

 

41

52

 

92.7

76.9

0.058

 

13

18

 

46.2

50.0

0.883

*p < 0.05 , **p < 0.005